Matthew Keith

发表

Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma

I. Pavord, G. Colice, M. Kraft, 2021, European Respiratory Journal.

610 EFFICACY AND SAFETY OF BENRALIZUMAB IN ADULTS AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 24-WEEK DOUBLE-BLIND PERIOD OF THE PHASE 3 MESSINA TRIAL

A. Bredenoord, E. Dellon, I. Hirano, 2023, Gastroenterology.

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.

A. Bredenoord, I. Hirano, J. Caldwell, 2024, The New England journal of medicine.